RedShiftBio Appoints Primetech as Exclusive Distributor in Japan
Burlington, MA - June 16 2020,​ RedShift BioAnalytics, Inc. (RedShiftBio) announced
its award winning AQS​3​™pro, based on Microfluidic Modulation Spectroscopy (MMS)
technology, is now available in Japan, following the appointment of Primetech as
exclusive distributor. This partnership follows the announcement in May of appointing
Topbiox as its distributor in China, and continuing RedShiftBio’s response to the rapid
growth in demand globally for its novel AQS​3​™pro instrument. Designed specifically forprotein characterization applications in the biopharmaceutical industry, the technology
has already seen wide adoption in the analytical toolkit of companies developing
life-saving biotherapeutics and vaccines.
The Japanese biopharmaceutical industry has seen an increased focus on biologics
development, especially biosimilar mAb therapeutics and vaccines. It is predicted that1biosimilars will pose a ~$550b opportunity in Japan over the next seven years , due tothe patent expiry of wave 2-3 biologics and a less stringent regulatory environment
versus the US for approval. The partnership with Primetech will satisfy the growing
demand from the biopharma industry for multi-functional, easy to use biophysicalcharacterization tools for protein secondary structural analysis. The AQS​3​pro allows
biopharmaceutical companies to accelerate and de-risk their drug development pipelines
with ultra-sensitive measurements of minute protein structural changes.
“The novel capabilities of the AQS​3​pro have already led to the rapid adoption bybiopharmaceutical companies in Europe and North America,” said Julien Bradley, CEOat RedShiftBio. “Primetech is working closely with the leading companies in this space,and has experience in introducing novel technologies. The company represents an ideal
partner to help support and capitalize on the large market opportunity in Japan for theAQS​3​pro.”"We are excited to start demonstrating the capabilities of the AQS​3​pro,” said Primetech
CEO, Ryosuke Ogihara. “With the AQS​3​pro, Japanese scientists can analyze theirsamples more efficiently and accurately." Primetech will be responsible for all sales,
marketing, service and support.
If you would like to find out more about the AQS​3​pro then visit
https://redshiftbio.com/mms​.
Ends

1"Japanese Biosimilars Landscape Study, 2009-2020"
131 Middlesex Turnpike​ | ​Burlington, MA 01803​ | ​T​: 781.345.7300​ | ​E​: info@redshiftbio.com

About RedShiftBio
RedShiftBio​Ⓡ​ is a provider of innovative analytical instrumentation for the research, development andmanufacture of protein therapeutic drugs. The company has developed a powerful new analytical technique,
Microfluidic Modulation Spectroscopy (MMS) that enables direct probing of the biophysical structure ofproteins. The patented MMS technology provides comprehensive secondary structure information acrossfive key measurements, in a single automated analysis, replacing the requirement to run samples on
multiple instruments. For further information, please visit​ ​www.redshiftbio.com/​ or email
info@redshiftbio.com
For media enquiries in Europe

For media enquiries in the USA

Contact:

Contact:

Claire England

Laura Browne

claire@covalentbonds.com​laura@covalentbonds.com+44 (0) 7808 020554+1 978 893 9618

About Primetech
Primetech is a unique company that can deliver overseas partners’ high-tech life science products andservices to researchers in Japan with equivalent technical capabilities as the original manufacturingcompany.
Primetech provides a first class solution to its Japanese customers featuring sales, marketing, applications
and technical support functions. The company also contributes to research results in the field of life sciencesin Japan. In addition, Primetech has its own life science laboratory in the University of Tokyo featuring theproducts it distributes, confirming, through personal experience, the value the products and services it offers
can provide to its customers.
For further information, please visit ​www.primetech.co.jp/​ or ​email info@primetech.co.jp

131 Middlesex Turnpike​ | ​Burlington, MA 01803​ | ​T​: 781.345.7300​ | ​E​: info@redshiftbio.com